Surface roughness modulates EGFR signaling and stemness of triple-negative breast cancer cells

被引:3
|
作者
Rosado-Galindo, Heizel [1 ]
Domenech, Maribella [1 ,2 ]
机构
[1] Univ Puerto Rico Mayaguez, Bioengn Program, Mayaguez, PR 00682 USA
[2] Univ Puerto Rico Mayaguez, Dept Chem Engn, Mayaguez, PR 00682 USA
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2023年 / 11卷
基金
美国国家卫生研究院;
关键词
topography; EGFR signaling; TNBC; secretome; stemness; PHASE-II; TARGETED THERAPY; GROWTH; PROLIFERATION; RESISTANCE; PROMOTES; OVEREXPRESSION; CHALLENGES; SIGNATURE; YAP/TAZ;
D O I
10.3389/fcell.2023.1124250
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Introduction: Cancer stem cells (CSC), a major culprit of drug-resistant phenotypes and tumor relapse, represent less than 2 % of the bulk of TNBC cells, making them difficult to isolate, study, and thus, limiting our understanding of the pathogenesis of the disease. Current methods for CSC enrichment, such as 3D spheroid culture, genetic modification, and stem cell conditioning, are time consuming, expensive, and unsuitable for high-throughput assays. One way to address these limitations is to use topographical stimuli to enhance CSC populations in planar culture. Physical cues in the breast tumor microenvironment can influence cell behavior through changes in the mechanical properties of the extracellular matrix (ECM). In this study, we used topographical cues on polystyrene films to investigate their effect on the proteome and stemness of standard TNBC cell lines.Methods: The topographical polystyrene-based array was generated using razor printing and polishing methods. Proteome data were analyzed and enriched bioprocesses were identified using R software. Stemness was assessed measuring CD44, CD24 and ALDH markers using flow cytometry, immunofluorescence, detection assays, and further validated with mammosphere assay. EGF/EGFR expression and activity was evaluated using enzyme-linked immunosorbent assay (ELISA), immunofluorescence and antibody membrane array. A dose-response assay was performed to further investigate the effect of surface topography on the sensitivity of cells to the EGFR inhibitor.Results: Surface roughness enriched the CSC population and modulated epidermal growth factor receptor (EGFR) signaling activity in TNBC cells. Enhanced proliferation of MDA-MB-468 cells in roughness correlated with upregulation of the epidermal growth factor (EGF) ligand, which in turn corresponded with a 3-fold increase in the expression of EGFR and a 42% increase in its phosphorylation compared to standard smooth culture surfaces. The results also demonstrated that phenotypic changes associated with topographical (roughness) stimuli significantly decreased the drug sensitivity to the EGFR inhibitor gefitinib. In addition, the proportion of CD44+/CD24-/ALDH+ was enhanced on surface roughness in both MDA-MB-231 and MDA-MB-468 cell lines. We also demonstrated that YAP/TAZ activation decreased in a roughness-dependent manner, confirming the mechanosensing effect of the topographies on the oncogenic activity of the cells.Discussion: Overall, this study demonstrates the potential of surface roughness as a culture strategy to influence oncogenic activity in TNBC cells and enrich CSC populations in planar cultures. Such a culture strategy may benefit high-throughput screening studies seeking to identify compounds with broader tumor efficacy.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] GABRP sustains the stemness of triple-negative breast cancer cells through EGFR signaling
    Li, Xiyin
    Wang, Hairui
    Yang, Xing
    Wang, Xiaoqi
    Zhao, Lina
    Zou, Li
    Yang, Qin
    Hou, Zongliu
    Tan, Jing
    Zhang, Honglei
    Nie, Jianyun
    Jiao, Baowei
    CANCER LETTERS, 2021, 514 : 90 - 102
  • [2] Moderate Exercise Modulates Tumor Metabolism of Triple-Negative Breast Cancer
    Vulczak, Anderson
    Souza, Anderson de Oliveira
    Ferrari, Gustavo Duarte
    Caleiro Seixas Azzolini, Ana Elisa
    Pereira-da-Silva, Gabriela
    Alberici, Luciane Carla
    CELLS, 2020, 9 (03)
  • [3] Signaling pathway inhibitors target breast cancer stem cells in triple-negative breast cancer
    Li, Wenlong
    Yang, Hongmei
    Li, Xiaoli
    Han, Lou
    Xu, Ning
    Shi, Aiping
    ONCOLOGY REPORTS, 2019, 41 (01) : 437 - 446
  • [4] Curcumin induces apoptosis of triple-negative breast cancer cells by inhibition of EGFR expression
    Sun, Xiao-Dong
    Liu, Xing-E
    Huang, Dong-Sheng
    MOLECULAR MEDICINE REPORTS, 2012, 6 (06) : 1267 - 1270
  • [5] RNF181 modulates Hippo signaling and triple negative breast cancer progression
    Zhou, Rui
    Ding, Yinlu
    Xue, Min
    Xiong, Bin
    Zhuang, Ting
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [6] Wnt signaling in triple-negative breast cancers: Its roles in molecular subtyping and cancer cell stemness and its crosstalk with non-coding RNAs
    Yang, Xinzhi
    Cao, Deliang
    Ma, Wenqian
    Gao, Shuqin
    Wen, Gebo
    Zhong, Jing
    LIFE SCIENCES, 2022, 300
  • [7] The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer
    Liu, Hui
    Paddock, Marcia N.
    Wang, Haibin
    Murphy, Charles J.
    Geck, Renee C.
    Navarro, Adrija J.
    Wulf, Gerburg M.
    Elemento, Olivier
    Haucke, Volker
    Cantley, Lewis C.
    Toker, Alex
    CANCER DISCOVERY, 2020, 10 (08) : 1226 - 1239
  • [8] PHLPP1 depletion promotes tumorigenesis and stemness in triple-negative breast cancer cells through AKT signaling
    Haque, Md Anwarul
    Poullikkas, Thanasis
    Al-Amin Kaisar, F. M.
    Haque, Shariful
    Khatun, Mst Hajera
    Mamun, Al
    Khan, Alam
    MEDICAL ONCOLOGY, 2025, 42 (03)
  • [9] Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells
    El Guerrab, Abderrahim
    Bamdad, Mahchid
    Bignon, Yves-Jean
    Penault-Llorca, Frederique
    Aubel, Corinne
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [10] The role of PRMT1 in EGFR methylation and signaling in MDA-MB-468 triple-negative breast cancer cells
    Nakai, Katsuya
    Xia, Weiya
    Liao, Hsin-Wei
    Saito, Mitsue
    Hung, Mien-Chie
    Yamaguchi, Hirohito
    BREAST CANCER, 2018, 25 (01) : 74 - 80